EU Approves Kimberly-Clark's $40B Kenvue Deal With Divestiture Conditions
KMB is trading near its 52-week low of $92.42 (5.4% above the low) on light trading volume (0.2× avg).
Summary
The European Commission has formally approved Kimberly-Clark's $40 billion acquisition of Kenvue, clearing a major regulatory hurdle. To address antitrust concerns, Kimberly-Clark must divest its entire feminine hygiene portfolio in the European Economic Area, including the Kotex, Camelia, and Record brands. This follows Australia's ACCC approval in September, which required divesting Kenvue's Carefree and Stayfree brands. The EU decision removes the last significant regulatory uncertainty for the deal, which is expected to close in the coming months. The divestitures are modest relative to the combined company's scale and were anticipated by the market.
At the time of this announcement, KMB was trading at $97.41 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $32.4B. The 52-week trading range was $92.42 to $123.09. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.